Covid-19 roundup: Brazil holds Sino­vac dos­es af­ter man­u­fac­tur­ing mix up; Take­da to pro­duce No­vavax vac­cine

The use of more than 12.1 mil­lion dos­es of the Chi­nese Sino­vac vac­cine will be halt­ed in Brazil, af­ter reg­u­la­tors learned that the man­u­fac­tur­ing site …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.